spending on GLP-1s soared: total annual spending reached nearly $72 billion in 2023 ( [20] ) and climbed to approximately $52.7 billion in US market revenue in 2025 (accounting for 75.3% of the global GLP-1 market), with projections pointing toward $155.9 billion by 2033 ( [21] )
In some cases, insurance policies may also cover Ozempic when healthcare professionals prescribe it to lower cholesterol and reduce the risk of other health complications, such as cardiovascular disease
Frailty in individuals may include at least three of the following symptoms: unintentional weight loss, exhaustion (poor endurance), weakness (low grip strength), slowness, and physical inactivity (115)
Access this article Similar content being viewed by others Data availability Data sharing not applicable to this article as no datasets were generated or analyzed during the current study
I never thought I would be the type to do Botox and fillers but they do such a good job and the staff feels like family now
My portion control has improved, and my snacking is minimal